The expression of metallothionein (MT) and proliferation intensity in ovarian cancers treated with cisplatin and paclitaxel.

MLA

Surowiak, Paweł, et al. “The Expression of Metallothionein (MT) and Proliferation Intensity in Ovarian Cancers Treated with Cisplatin and Paclitaxel.” Folia Morphologica, vol. 62, no. 4, Nov. 2003, pp. 493–95. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=14655150&authtype=sso&custid=ns315887.

APA

Surowiak, P., Kaplenko, I., Spaczyński, M., & Zabel, M. (2003). The expression of metallothionein (MT) and proliferation intensity in ovarian cancers treated with cisplatin and paclitaxel. Folia Morphologica, 62(4), 493–495.

Chicago

Surowiak, Paweł, Irina Kaplenko, Marek Spaczyński, and Maciej Zabel. 2003. “The Expression of Metallothionein (MT) and Proliferation Intensity in Ovarian Cancers Treated with Cisplatin and Paclitaxel.” Folia Morphologica 62 (4): 493–95. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=14655150&authtype=sso&custid=ns315887.